Collier Kathryn J 4
4 · Regulus Therapeutics Inc. · Filed Aug 14, 2023
Insider Transaction Report
Form 4
Collier Kathryn J
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-08-10+15,000→ 15,000 totalExercise: $1.36Exp: 2033-08-09→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The options will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant, subject to the Reporting Person's continuous service.